Trials / Completed
CompletedNCT06467487
Electronic Health Record Strategies to Promote Diverse Participation in Research AIM 2
Leveraging Community Engagement and Electronic Health Record Strategies to Promote Diverse Participation in COVID-19 Clinical Trials -2
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 214,526 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Based on the outcomes of the initial study (NCT05348603), this optimization study will employ the most effective interventions (letters and messages) and distribute these communications to underrepresented minorities to further promote interest in research. Optimized language will be distributed in English, Spanish, Portuguese, Chinese, Arabic, or Haitian Creole, based on preferred language identified in the patient profile in an electronic medical records system.
Detailed description
The primary objective of the optimization study is to examine the effectiveness on increasing interest in research of an optimized letter versus a generic letter; an optimized message versus a generic message; and an optimized letter and an optimized message versus a generic letter and a generic message. The secondary objective of the optimization study is to examine the effectiveness on increasing participation in research of an optimized letter versus a generic letter, an optimized message versus a generic message, an optimized letter and an optimized message versus a generic letter and a generic message.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Traditional Letter | Patients receive a traditional letter. |
| OTHER | Direct to Patient Message | Patients receive a direct to patient message via the portal. |
| OTHER | Optimized Letter | Patients receive an optimized letter. |
| OTHER | Direct to Patient Message - Optimized | Patients receive an optimized direct to patient message via the portal. |
Timeline
- Start date
- 2024-09-04
- Primary completion
- 2025-01-06
- Completion
- 2025-01-06
- First posted
- 2024-06-21
- Last updated
- 2025-01-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06467487. Inclusion in this directory is not an endorsement.